Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.

Renn, Marcel; Bartok, Eva; Zillinger, Thomas; Hartmann, Gunther; Behrendt, Rayk

Renn, Marcel; Bartok, Eva; Zillinger, Thomas; Hartmann, Gunther; Behrendt, Rayk.

Afiliação

Renn M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; Mildred Scheel School of Oncology, University Hospital Bonn, Medical Faculty, 53127 Bonn, Germany.
Bartok E; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; Unit of Experimental Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Zillinger T; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; Institute of Immunology, School of Medicine, Philipps University Marburg, 35043 Marburg, Germany.
Hartmann G; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.
Behrendt R; Institute for Immunology, Technische Universität Dresden, Medical Faculty Carl Gustav Carus, 01307 Dresden, Germany. Electronic address: rayk.behrendt@tu-dresden.de.

Pharmacol Ther ; 228: 107931, 2021 12.

Article em En | MEDLINE | ID: mdl-34171328

Assuntos

Tratamento Farmacológico da COVID-19; Modelos Animais de Doenças; Desenvolvimento de Medicamentos; Animais

Palavras-chave

Animal models; Antiviral immunity; COVID-19; SARS-CoV-2; Vaccine; Virus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Modelos Animais de Doenças / Desenvolvimento de Medicamentos / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google